These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 37867629)
1. Ginsenoside Rb1 Promotes Hepatic Glycogen Synthesis to Ameliorate T2DM Through 15-PGDH/PGE Liang M; Zhan W; Wang L; Bei W; Wang W Diabetes Metab Syndr Obes; 2023; 16():3223-3234. PubMed ID: 37867629 [TBL] [Abstract][Full Text] [Related]
2. The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE Liang M; Wang L; Wang W Cell Signal; 2023 Aug; 108():110707. PubMed ID: 37164143 [TBL] [Abstract][Full Text] [Related]
3. 15-Hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates hepatic abnormal lipid metabolism, ER stress, and inflammation through PGE Wang W; Liang M; Wang L; Bei W; Guo J Bioorg Chem; 2023 Aug; 137():106646. PubMed ID: 37285764 [TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128 [TBL] [Abstract][Full Text] [Related]
5. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury. Yao L; Chen W; Song K; Han C; Gandhi CR; Lim K; Wu T PLoS One; 2017; 12(4):e0176106. PubMed ID: 28423012 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of 15-hydroxyprostaglandin dehydrogenase protects neurons from ferroptosis in ischemic stroke. Xu Y; Li K; Zhao Y; Zhou L; He N; Qiao H; Xu Q; Zhang H; Liu Y; Zhao J MedComm (2020); 2024 Jan; 5(1):e452. PubMed ID: 38188604 [TBL] [Abstract][Full Text] [Related]
7. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967 [TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles. Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256 [TBL] [Abstract][Full Text] [Related]
9. Sanhuang xiexin decoction synergizes insulin/PI3K-Akt/FoxO signaling pathway to inhibit hepatic glucose production and alleviate T2DM. Chen D; Chen X; He C; Xiao C; Chen Z; Chen Q; Chen J; Bo H J Ethnopharmacol; 2023 Apr; 306():116162. PubMed ID: 36646159 [TBL] [Abstract][Full Text] [Related]
10. The regulatory mechanism involved in the prostaglandin E Shimada H; Hashimoto R; Aoki A; Yamada S; Oba KI; Kawase A; Nakanishi T; Iwaki M Prostaglandins Leukot Essent Fatty Acids; 2020 Apr; 155():102081. PubMed ID: 32155568 [TBL] [Abstract][Full Text] [Related]
11. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma. Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of 15-PGDH prevents ischemic renal injury by the PGE Kim HJ; Kim SH; Kim M; Baik H; Park SJ; Kang MS; Kim DH; Kim BW; Markowitz SD; Bae KB Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1054-F1066. PubMed ID: 33135478 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanisms. Kishore AH; Owens D; Word RA J Clin Endocrinol Metab; 2014 Mar; 99(3):1006-18. PubMed ID: 24471568 [TBL] [Abstract][Full Text] [Related]
16. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer. Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980 [TBL] [Abstract][Full Text] [Related]
17. 15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins. Lu D; Han C; Wu T J Biol Chem; 2013 Jul; 288(27):19484-502. PubMed ID: 23687300 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 alterations during sepsis are partially mediated by endotoxin-induced inhibition of prostaglandin 15-hydroxydehydrogenase. Hahn EL; Clancy KD; Tai HH; Ricken JD; He LK; Gamelli RL J Trauma; 1998 May; 44(5):777-81; discussion 781-2. PubMed ID: 9603077 [TBL] [Abstract][Full Text] [Related]
19. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells. Kim HR; Lee HN; Lim K; Surh YJ; Na HK Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924 [TBL] [Abstract][Full Text] [Related]